Am Fam Physician. 2013 Apr 1;87(7):online.
Original Article: Chronic Fatigue Syndrome: Diagnosis and Treatment
Issue Date: October 15, 2012
Available at: http://www.aafp.org/afp/2012/1015/p741.html
TO THE EDITOR: We feel that the overview of the diagnosis and treatment of chronic fatigue syndrome (CFS) was incomplete and did not reflect current best treatment practices. The discussion of current CFS research omitted key studies, such as evidence from prospective cohort studies indicating that up to 10 percent of patients with postinfectious syndromes develop CFS, regardless of the type of infectious agent.1 Biomarker research has shown distinct patterns of gene expression correlating with cytokine, adrenergic, and sensory receptor changes after modest exercise in patients with CFS compared with healthy sedentary patients.2 Indeed, many peer-reviewed publications support a physiologic etiology of CFS.
The authors emphasize behavioral treatments for CFS, but we have found these treatments to be effective only in helping patients cope with the illness. Graded exercise therapy (GET) should be administered with great caution by physicians familiar with CFS, because even mild exercise can provoke postexertional malaise and severe symptom flare-up that correlate with gene expression findings.3 The authors also do not address diagnosis and management of orthostatic intolerance, a common and significant issue for patients with CFS.4
Health care professionals should avail themselves of expert resources to provide the best care to patients with CFS. The Centers for Disease Control and Prevention offers continuing medical education courses on CFS at http://www.cdc.gov/cfs/education/index.html. A free primer published by the International Association for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis is available at http://www.iacfsme.org/Home/Primer/tabid/509/Default.aspx.
CFS is a physically debilitating illness that places great burdens on patients and their families. Primary care physicians who understand the physical complexities of the illness will be able to better assist these patients in managing this serious chronic illness.
1. Hickie I, Davenport T, Wakefield D, et al. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ. 2006;333(7568):575.
2. Light AR, Bateman L, Jo D, et al. Gene expression alterations at baseline and following moderate exercise in patients with chronic fatigue syndrome and fibromyalgia. J Intern Med. 2012;271(1):64–81.
3. Davenport TE, Stevens SR, VanNess MJ, Snell CR, Little T. Conceptual model for physical therapist management of chronic fatigue syndrome/myalgic encephalomyelitis. Phys Ther. 2010;90(4):602–614.
4. Rowe PC. Orthostatic intolerance and CFS: new light on an old problem. J Pediatr. 2002;40(4):387–389.
IN REPLY: We appreciate this thoughtful letter. We do not dispute a physiologic etiology for CFS; our article mentions both postinfectious and genetic factors as possible contributors to the syndrome. Because there is no known cure for CFS, the family physician should assist patients in coping with symptoms in the most effective way possible. We emphasized behavioral treatments, not to imply that the etiology of CFS is psychological, but because the weight of evidence favors them at this time.
The PACE trial was by far the largest and best-designed study of treatments for CFS. It was a randomized controlled trial demonstrating that cognitive behavior therapy (CBT) and GET have moderate benefit in persons with CFS. Both were superior to specialist care alone and adaptive pacing therapy, defined as “helping the participant to plan and pace activity to reduce or avoid fatigue.”1 We did not cite the International Association for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis primer because it was published after our literature search date. Although the primer contains useful information for family physicians treating CFS, it deemphasizes CBT and GET because although they “may improve coping strategies,” they do not “cure the illness.”2
Some have expressed concerns that the PACE trial interventions could be harmful3; however, there was no difference in adverse events between the CBT and GET groups and the pacing therapy and specialist care groups.
Because postexertional malaise is a hallmark of CFS, it is easy to conceive how therapies focused on increasing activity that are supervised by those who do not understand the illness could lead, and likely have led, to exacerbation of symptoms in some cases. I concur with Drs. Bateman and Spotila that family physicians should refer patients for these therapies only to specialists with expertise in CFS and the dangers of overexertion. In addition, the results of the PACE trial should not be generalized to patients with severe CFS (e.g., those who are bed-bound). Applied safely and appropriately, however, CBT and GET may help patients with CFS cope with this disabling illness.
1. White PD, Goldsmith KA, Johnson AL, et al.; PACE trial management group. Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial. Lancet. 2011;377(9768):823–836.
2. Chronic fatigue syndrome/myalgic encephalomyelitis: a primer for clinical practitioners. 2012. http://www.iacfsme.org/Portals/0/PDF/PrimerFinal3.pdf. Accessed January 11, 2013.
3. Kindlon T. Reporting of harms associated with graded exercise therapy and cognitive behavioural therapy in myalgic encephalomyelitis/chronic fatigue syndrome. Bulletin of the IACFS/ME. 2011;19(2):59–111. http://www.iacfs.net/. Accessed January 11, 2013.
Send letters to Kenneth W. Lin, MD, MPH, Associate Deputy Editor for AFP Online, e-mail: email@example.com, or 11400 Tomahawk Creek Pkwy., Leawood, KS 66211-2680.
Please include your complete address, e-mail address, and telephone number. Letters should be fewer than 400 words and limited to six references, one table or figure, and three authors.
Letters submitted for publication in AFP must not be submitted to any other publication. Possible conflicts of interest must be disclosed at time of submission. Submission of a letter will be construed as granting the American Academy of Family Physicians permission to publish the letter in any of its publications in any form. The editors may edit letters to meet style and space requirements.
Copyright © 2013 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact firstname.lastname@example.org for copyright questions and/or permission requests.
Want to use this article elsewhere? Get Permissions